Literature DB >> 21042055

Combination prevention: a deeper understanding of effective HIV prevention.

Catherine A Hankins1, Barbara O de Zalduondo.   

Abstract

Evidence-informed and human rights-based combination prevention combines behavioural, biomedical, and structural interventions to address both the immediate risks and underlying causes of vulnerability to HIV infection, and the pathways that link them. Because these are context-specific, no single prescription or standard package will apply universally. Anchored in 'know your epidemic' estimates of where the next 1000 infections will occur and 'know your response' analyses of resource allocation and programming gaps, combination prevention strategies seek to realign programme priorities for maximum effect to reduce epidemic reproductive rates at local, regional, and national levels. Effective prevention means tailoring programmes to local epidemics and ensuring that components are delivered with the intensity, quality, and scale necessary to achieve intended effects. Structural interventions, addressing the social, economic, cultural, and legal constraints that create HIV risk environments and undermine the agency of individuals to protect themselves and others, are also public goods in their own right. Applying the principles of combination prevention systematically and consistently in HIV programme planning, with due attention to context, can increase HIV programme effectiveness. Better outcome and impact measurement using multiple methods and data triangulation can build the evidence base on synergies between the components of combination prevention at individual, group, and societal levels, facilitating iterative knowledge translation within and among programmes.

Entities:  

Mesh:

Year:  2010        PMID: 21042055     DOI: 10.1097/01.aids.0000390709.04255.fd

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  79 in total

1.  Operational research to improve HIV prevention in the United States.

Authors:  Jeffrey H Herbst; Marlene Glassman; James W Carey; Thomas M Painter; Deborah J Gelaude; Amy M Fasula; Jerris L Raiford; Arin E Freeman; Camilla Harshbarger; Abigail H Viall; David W Purcell
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

2.  Passing the baton: Community-based ethnography to design a randomized clinical trial on the effectiveness of oral pre-exposure prophylaxis for HIV prevention among Black men who have sex with men.

Authors:  Jonathan Garcia; Paul W Colson; Caroline Parker; Jennifer S Hirsch
Journal:  Contemp Clin Trials       Date:  2015-11-09       Impact factor: 2.226

Review 3.  Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Authors:  Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

4.  Rethinking health research capacity strengthening.

Authors:  Emily E Vasquez; Jennifer S Hirsch; Le Minh Giang; Richard G Parker
Journal:  Glob Public Health       Date:  2013-05-07

5.  Modeling the impact of RV144-like vaccines on HIV transmission.

Authors:  Catherine A Hankins; John W Glasser; Robert T Chen
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

6.  Acceptability and feasibility of cash transfers for HIV prevention among adolescent South African women.

Authors:  Catherine MacPhail; Michelle Adato; Kathleen Kahn; Amanda Selin; Rhian Twine; Samson Khoza; Molly Rosenberg; Nadia Nguyen; Elizabeth Becker; Audrey Pettifor
Journal:  AIDS Behav       Date:  2013-09

7.  Does Economic Strengthening Improve Viral Suppression Among Adolescents Living with HIV? Results From a Cluster Randomized Trial in Uganda.

Authors:  Laura Gauer Bermudez; Fred M Ssewamala; Torsten B Neilands; Lily Lu; Larissa Jennings; Gertrude Nakigozi; Claude A Mellins; Mary McKay; Miriam Mukasa
Journal:  AIDS Behav       Date:  2018-11

8.  Conceptualizing a Human Right to Prevention in Global HIV/AIDS Policy.

Authors:  Benjamin Mason Meier; Kristen Nichole Brugh; Yasmin Halima
Journal:  Public Health Ethics       Date:  2012-12-05       Impact factor: 1.940

9.  Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Authors:  Elisa F Long; Robert R Stavert
Journal:  J Gen Intern Med       Date:  2013-04-16       Impact factor: 5.128

10.  Understanding female migrant child labor within a cumulative risk framework: The case for combined interventions in Ghana.

Authors:  Laura Gauer Bermudez; Ozge Sensoy Bahar; Mavis Dako-Gyeke; Alice Boateng; Abdallah Ibrahim; Fred M Ssewamala; Mary McKay
Journal:  Int Soc Work       Date:  2018-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.